| 标题 |
Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology |
| 网址 | |
| DOI | |
| 其它 |
期刊:International Journal of Clinical Oncology 作者:Michiyasu Murakami; Yoshiharu Miyata; Kazuhisa Nakashima; Masakazu Abé; Junichi Nishimura; et al 出版日期:2024-11-21 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)